HIV
Lack of mental health treatment available for HIV patients in the UK
March 6, 2020Medical Communications AIDS, HIV, HIV AIDS, HIV treatment, HIV/AIDS
A cross-party group of MPs have said that those with HIV do not have access to adequate mental health treatment. …
Rapid testing to help combat worst UK outbreak of HIV in 30 years
February 18, 2020Manufacturing and Production AIDS, HIV, HIV England, HIV Scotland, HIV epidemic, HIV/AIDS
New HIV tests that provide results in minutes are being used in Glasgow to fight a recent outbreak of HIV. …
Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds
February 5, 2020Research and Development AIDS, HIV, STDs, STIs, UK, sexual health
The UK faces a new Sexually Transmitted Infection (STI) diagnoses every 70 seconds, according to a new report that outlines …
National Institutes of Health terminates HIV vaccine after it proves ineffective
February 4, 2020Manufacturing and Production HIV, pharma
A trial investigating the efficacy of a new HIV vaccine conducted by the National Institute of Allergy and Infectious Diseases …
HIV infections fall by 73% in bi and gay British men
January 16, 2020Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland
Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% …
SMC gives nod for access to new HIV treatment Dovato
September 10, 2019Manufacturing and Production HIV, SMC
The Scottish Medicines Consortium (SMC) has approved Dovato (dolutegravir/lamivudine) for use on the NHS, allowing treatment of individuals with a …
Gilead challenges Government over patents on preventative HIV drug Truvada
August 22, 2019Research and Development, Sales and Marketing AIDS, CDC, Gilead, HIV, IP, PrEP, Truvada, government, patents
Gilead is challenging the US Government’s patents on PrEP drug Truvada. The Foster City firm has submitted a challenge to …
GSK’s two drug HIV regimen effective when administered every two months
August 22, 2019Research and Development AIDS, GSK, HIV, ViiV Healthcare, viral supression
GSK’s long-acting, two-drug HIV regimen was as effective in supressing patient’s viral loads when administered every two months (eight weeks), …
Top Ten most popular articles on Pharmafile.com this week!
August 16, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Air pollution, CAR-T therapy, HIV, Kymriah, Medicare, Novartis, Yescarta, Zolgensma
Novartis’ faulty data scandal dominated the headlines this week, as the Swiss firm faced fierce backlash over covering up the …
Scientists use duoCAR-T therapy to fight HIV
August 9, 2019Medical Communications AIDS, CAR-T therapy, HIV, health, immunotherapy, pharma
Researchers from the University of Pittsburgh, working with the biotech Lentigen, have found that an advanced form of CAR-T therapy …
Gilead’s PrEP drug Descovy should be approved for men and transgender women but not cis-gender women, FDA advisory panel says
August 8, 2019Research and Development AIDS, Gilead, HIV, PrEP, descovy, pharma
Independent experts on a panel advising the FDA have voted in favour of Gilead’s new PrEP drug Descovy in men …
MSD trials long lasting PrEP implant for preventing HIV
July 23, 2019Research and Development AIDS, HIV, MSD, PrEP, pharma
MSD is trialling an implant that prevents patients from contracting HIV, The Guardian has said. The US firm has tested …
ViiV Healthcare’s two drug HIV therapy beats Gilead’s three drug treatment in Phase 3 trial
July 10, 2019Research and Development AIDS, Dovato, GSK, Gilead, HIV, ViiV, pharma
Pfizer and GlaxoSmithKline’s HIV company, ViiV Healthcare, has said its two-drug combo Dovato (dolutegravir and lamuvidine) met its primary endpoint …
GSK opens new manufacturing plants in Singapore
July 5, 2019Manufacturing and Production Asia, HIV, Singapore, anaemia, facilities, manufacturing, pharma
British multinational GlaxoSmithKline has opened two new manufacturing plants in Singapore. The UK firm has also expanded facilities at its …
Top Ten most popular articles on Pharmafile.com this week!
July 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brenntag, Elizabeth Warren, HIV, Novartis, PrEP, cannabis, crispr, pharma
The top story of this week covered Novartis’ announcement that they did not send chemicals that could be used to …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
